Common alleles at 6q25.1 and 1 p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriersANTONIOU, Antonis C; KARTSONAKI, Christiana; ZAFFARONI, Daniela et al.Human molecular genetics (Print). 2011, Vol 20, Num 16, pp 3304-3321, issn 0964-6906, 18 p.Article

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?NAROD, Steven A; METCALFE, Kelly; ROBSON, Mark et al.Breast cancer research and treatment. 2013, Vol 138, Num 1, pp 273-279, issn 0167-6806, 7 p.Article

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation CarriersCOUCH, Fergus J; GAUDET, Mia M; MCGUFFOG, Lesley et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 4, pp 645-657, issn 1055-9965, 13 p.Article

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk PredictionANTONIOU, Antonis C; BEESLEY, Jonathan; ISAACS, Claudine et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9742-9754, issn 0008-5472, 13 p.Article